Why it may help PMS: Eases cramps and nausea
PMS
Get updatesOverview
Premenstrual Syndrome (PMS) refers to a group of physical, emotional, and behavioral symptoms that occur in the luteal phase of the menstrual cycle and resolve with the onset of menstruation.
When to seek urgent medical care
- Symptoms that are severe and debilitating, interfering with daily life
- Thoughts of self-harm or suicide
- Symptoms that do not resolve with menstruation
- Unexplained heavy bleeding or severe pain
- New or worsening symptoms after age 40
- Symptoms that are significantly different from previous cycles
Common symptoms
- Mood swings
- Irritability
- Anxiety
- Bloating
- Breast tenderness
- Headache
- Fatigue
- Food cravings
- Sleep disturbances
- Difficulty concentrating
Possible contributors
- Fluctuating hormone levels (estrogen, progesterone)
- Neurotransmitter imbalances (serotonin)
- Genetic predisposition
- Stress
- Nutritional deficiencies (magnesium, calcium, B6)
- Inflammation
- Lifestyle factors (diet, exercise, sleep)
Labs to discuss with your clinician
- Complete Blood Count (CBC)
- Thyroid Stimulating Hormone (TSH)
- Vitamin D levels
- Magnesium levels
- Calcium levels
- Hormone panel (estrogen, progesterone, FSH, LH - if irregular cycles)
All Remedies
Ranked by community outcomes, then evidence grade, Health Voice mentions, and recency.
Remedies
Why it may help PMS: Deficiency worsens PMS
Why it may help PMS: St. John's Wort is best known for depression but may help PMS mood symptoms due to its serotonergic and dopaminergic effects; evidence specifically for PMS is limited.
Why it may help PMS: Vitamin B6 is involved in neurotransmitter synthesis (serotonin, dopamine, GABA) and has been shown in trials to improve PMS mood symptoms, irritability, and depression.
- Typical dose
- 50-100 mg/day
- Mechanism
- Involved in neurotransmitter synthesis, potentially alleviating mood symptoms.
- Notes
- High doses (over 100 mg/day long-term) can cause neuropathy.
- Evidence
- moderate
Why it may help PMS: Rhodiola rosea, an adaptogen, may help alleviate PMS-related fatigue and mood symptoms by modulating the body's stress response and neurotransmitter activity.
Why it may help PMS: Calcium supplementation has strong clinical evidence for reducing PMS mood and physical symptoms, likely by influencing neurotransmitter activity and smooth muscle function.
- Typical dose
- 1000-1200 mg/day
- Mechanism
- May help reduce physical and emotional PMS symptoms.
- Notes
- Best absorbed when taken with Vitamin D. Can be split into two doses.
- Evidence
- moderate
Why it may help PMS: Vitex (Chaste Tree) may alleviate PMS symptoms by modulating prolactin levels and balancing the estrogen-progesterone ratio, thereby addressing hormonal imbalances contributing to the condition.
Emerging Research
Why it may help PMS: Reduces mood and physical symptoms
Why it may help PMS: Improves PMS in PCOS
Why it may help PMS: B6 reduces PMS
Why it may help PMS: Krill oil's omega-3 fatty acids, particularly EPA and DHA, may reduce inflammation and modulate prostaglandin synthesis, thereby alleviating some physical and emotional symptoms associated with PMS.
Why it may help PMS: Evening primrose oil provides gamma-linolenic acid (GLA), which may help with PMS-related breast tenderness and inflammation, though evidence quality is mixed.
Why it may help PMS: Regular exercise can alleviate PMS symptoms by reducing stress and improving mood through the release of endorphins, and by potentially modulating hormonal fluctuations.
Why it may help PMS: Reduces PMS symptoms
- Typical dose
- 200-400 mg/day
- Mechanism
- May help reduce fluid retention, breast tenderness, and mood symptoms.
- Notes
- Magnesium Glycinate or Citrate forms are often well-tolerated.
- Evidence
- moderate
Why it may help PMS: Reduces PMS mood symptoms
- Typical dose
- 30 mg/day
- Mechanism
- May influence serotonin levels, improving mood symptoms.
- Notes
- Generally well-tolerated, but consult a healthcare provider if taking antidepressants.
- Evidence
- moderate
Why it may help PMS: Calms PMS-related anxiety
Why it may help PMS: Multiple RCTs and meta-analyses show chasteberry significantly reduces PMS symptoms including irritability, breast tenderness, bloating, and mood changes by modulating prolactin and supporting luteal phase progesterone.
- Typical dose
- 20-40 mg/day (extract)
- Mechanism
- May influence prolactin levels and dopamine, potentially easing breast pain and mood swings.
- Notes
- May take 2-3 cycles to see full effects. Do not use with hormonal contraceptives without medical advice.
- Evidence
- strong
Why it may help PMS: Magnesium may help relieve PMS-related water retention, breast tenderness, and mood symptoms; it also supports muscle relaxation and may work synergistically with vitamin B6.
- Typical dose
- 200-400 mg/day
- Mechanism
- May help reduce fluid retention, breast tenderness, and mood symptoms.
- Notes
- Magnesium Glycinate or Citrate forms are often well-tolerated.
- Evidence
- moderate
Why it may help PMS: Omega-3 fatty acids, particularly EPA, can reduce inflammation and modulate prostaglandin synthesis, which may alleviate physical symptoms like breast tenderness and cramping associated with PMS.
- Typical dose
- 1000-2000 mg EPA+DHA/day
- Mechanism
- Anti-inflammatory effects may help reduce pain and mood symptoms.
- Notes
- Choose a high-quality supplement with good EPA/DHA ratio.
- Evidence
- moderate
Why it may help PMS: Ashwagandha, as an adaptogen, may help alleviate PMS symptoms by reducing stress and anxiety, which can exacerbate mood disturbances and physical discomfort during the premenstrual phase.
Active B12 form essential for nerve function and red blood cell production.
A root that has been studied for sleep onset and mild anxiety.
Community outcomes
What people report for PMS
Self-reported by community members · not medical advice.
What people report for this condition
Self-reported community outcomes. Not medical advice. Requires at least three reports per remedy to surface.
Community outcome data is still being collected for this ailment.
Be the first to share your experience →People Like Me insights
As more members share outcomes, RemedyAtlas will show which remedies helped people with similar conditions, symptoms, goals, and lab patterns.
Community discussion
Structured experience reports from people managing this condition. Not medical advice.
You can share without an account — we'll send a one-time code to verify your email. Or sign in.
Loading posts…
Community Discussions
What people say about PMS
Lifestyle foundations
- Regular physical activity
- Stress management techniques
- Adequate sleep hygiene
- Balanced nutrition
- Avoidance of excessive caffeine and alcohol
- Hydration
Dietary recommendations
- Anti-inflammatory diet
- Increase omega-3 rich foods
- Limit refined carbohydrates
- Reduce sodium intake
- Increase fiber intake
- Adequate calcium and magnesium intake
- Limit caffeine
- Limit alcohol
Lifestyle interventions
- Aerobic exercise 30-60 min, 3-5x/week
- Strength training 2-3x/week
- 7-9 hours quality sleep nightly, consistent bedtime
- Daily mindfulness meditation or deep breathing for 10-15 min
- Yoga or Pilates 2-3x/week
- Journaling to track symptoms and emotional patterns
- Limit screen time before bed
Evidence at a glance
Strong Evidence
Moderate Evidence
Traditional Use
International evidence & guidelines
How global health authorities view PMS.
The National Center for Complementary and Integrative Health (NCCIH) acknowledges that some complementary health approaches, such as certain dietary supplements (e.g., calcium, magnesium, vitamin B6, chasteberry) and mind-body practices (e.g., yoga, meditation), have been studied for PMS. While some show promise, NCCIH emphasizes the need for more rigorous research. The Mayo Clinic also suggests lifestyle changes and certain supplements as potential aids for PMS symptoms, often recommending consultation with a healthcare provider before starting new supplements. The World Health Organization (WHO) and NHS generally advise lifestyle modifications as a first-line approach for mild to moderate PMS.
Evidence ecosystem
Indexed studies for PMS, grouped by source type and quality.
Filter by source type
Meta-Analyses(17)
Pooled analyses across multiple human trials.
Stereotactic radiosurgery in pituitary metastases: a systematic review and meta-analysis.
Hajikarimloo B, Tos SM, Alvani MS, Kooshki A, Mohammadzadeh I, Najari D · Radiation oncology (London, England) · 2025
The pituitary gland is an infrequent site for metastasis, encompassing approximately 0.4% of all intracranial metastatic lesions. The prognosis of pituitary metastasis (PM) remains dismal despite considerable advances in therapeutic interventions. Stereotactic radiosurgery (SRS) has been increasingly utilized as a minimally invasive therapeutic option for PMs. This study evaluated the efficacy and safety of SRS in patients with PMs. On November 26, 2024, a systematic search was conducted through PubMed, Embase, Scopus, and Web of Science. Studies that have evaluated the role of SRS in PMs or PMs with cavernous sinus invasion were included. The meta-analysis, sensitivity analysis, publication bias evaluation, and meta-regression were conducted using the R program. Seven studies with 79 individuals with PMs were included. The results showed a pooled local control (LC) rate of 92% (95%CI:83-98%) following intervention. The analysis resulted in a pooled diabetes insipidus (DI) improvemen
Meta-AnalysisPubMedVery High QualityBengi D, Strawbridge R, Drorian M, Juruena MF, Young A, Frey BN · The British journal of psychiatry : the journal of mental science · 2025 · n=3646
Mood disorders are among the leading causes of disease burden worldwide, with 20-70% of affected individuals experiencing comorbid premenstrual disorders. This systematic review and meta-analysis investigated the comorbidity of premenstrual dysphoric disorder (PMDD) or premenstrual syndrome (PMS) with non-reproductive mood disorders. We aimed to determine the pooled prevalence of PMDD/PMS with adult mood disorders, assess the impact of comorbidity on clinical course and summarise the associated neurobiological findings. Eligible studies were identified through Embase, MEDLINE and APA PsycINFO from inception to 22 January 2024 (PROSPERO, no. CRD42021246796). Studies on women ('females') with diagnoses of PMDD/PMS and mood disorders were included. Risk of bias was assessed using National Institutes of Health quality assessment tools. A random-effects, pooled-prevalence meta-analysis was conducted using the Comprehensive Meta-Analysis software, categorising diagnosti
Meta-AnalysisPubMedVery High QualityLiao Y, Sun Y, Guo J, Kang Z, Sun Y, Zhang Y · EBioMedicine · 2024
Understanding the impact of CYP2D6 metabolism on paroxetine, a widely used antidepressant, is essential for precision dosing. We conducted an 8-week, multi-center, single-drug, 2-week wash period prospective cohort study in 921 Chinese Han patients with depressive or anxiety disorders (ChiCTR2000038462). We performed CYP2D6 genotyping (single nucleotide variant and copy number variant) to derive the CYP2D6 activity score and evaluated paroxetine treatment outcomes including steady-state concentration, treatment efficacy, and adverse reaction. CYP2D6 metabolizer status was categorized into poor metabolizers (PMs), intermediate metabolizers (IMs), extensive metabolizers (EMs), and ultrarapid metabolizers (UMs). The influence of CYP2D6 metabolic phenotype on paroxetine treatment outcomes was examined using multiple regression analysis and cross-ethnic meta-analysis. The therapeutic reference range of paroxetine was estimated by receiver operating characteristic (ROC) analyses. Afte
Meta-AnalysisPubMedVery High Quality
Systematic Reviews(11)
Structured reviews of the full body of evidence (incl. Cochrane).
Robinson J, Ferreira A, Iacovou M, Kellow NJ · Nutrition reviews · 2025 · n=3254
Premenstrual syndrome (PMS) affects approximately 48% of women of reproductive age worldwide. It can lead to functional impairment, lower quality of life, and decreased work productivity. Despite the availability of medical treatment options, women are seeking alternative interventions because of concerns of harmful side effects and limited evidence of efficacy associated with pharmacological treatments. To date, high-quality research investigating the effects of dietary and nutrient intervention on PMS is limited. This systematic review investigated the effect of nutritional interventions on the psychological symptoms of PMS. Five electronic databases were searched for randomized controlled trials (RCTs) published in English from inception to October 2022. Trials eligible for inclusion were nutritional intervention studies involving women of reproductive age that measured PMS-associated psychological outcomes. Articles were selected using prespecified inclusion criteria. Data scree
Systematic ReviewPubMedVery High QualityNexha A, Caropreso L, de Azevedo Cardoso T, Suh JS, Tonon AC, Frey BN · BMC women's health · 2024
Women with premenstrual syndrome (PMS) and premenstrual dysphoric disorder (PMDD) typically experience a range of psychological and physiological symptoms that negatively affect their quality of life. Disruption in biological rhythms, including alterations of the sleep-wake cycle, have been implicated in PMS/PMDD, though literature is still growing to substantiate these findings. The objective of this study is to systematically review the available literature on biological rhythms disruption in PMS/PMDD. A literature search was conducted on four databases (Pubmed, Embase, Medline, and Web of Science) on December 3rd, 2021. This search yielded a total of 575 articles that assessed the relationship between biological rhythms and PMS/PMDD/premenstrual symptoms. After the exclusion of irrelevant articles and hand-searching references, 25 articles were included in this systematic review. Some studies showed that women with PMS/PMDD present lower melatonin levels, elevated nighttime core b
Systematic ReviewPubMedVery High QualityTaim BC, Ó Catháin C, Renard M, Elliott-Sale KJ, Madigan S, Ní Chéilleachair N · Sports medicine (Auckland, N.Z.) · 2023
Menstrual cycle (MC) disorders and MC-related symptoms can have debilitating effects on the health and performance of female athletes. As the participation of women in sports continues to increase, understanding the prevalence of a range of MC disorders and MC-related symptoms may guide preventive strategies to protect the health and optimise the performance of female athletes. To examine the prevalence of MC disorders and MC-related symptoms among female athletes who are not using hormonal contraceptives and evaluate the assessment methods used to identify MC disorders and MC-related symptoms. This systematic review was performed in accordance with the Preferred Reporting Items for Systematic reviews and Meta-Analyses (PRISMA). Six databases were searched until September 2022 for all original research that reported the prevalence of MC disorders and/or MC-related symptoms in athletes not using hormonal contraceptives, which included the definitions of the MC disorders examined,
Systematic ReviewPubMedVery High Quality
Clinical Guidelines(2)
Recommendations from medical societies (NICE, AHA, ADA, ACG, Endocrine Society…).
American College of Obstetricians and Gynecologists (ACOG)
This FAQ provides an overview of premenstrual syndrome, including symptoms, diagnosis, and treatment options. It is a patient-oriented resource offering general guidance.
Clinical GuidelineAmerican College of Obstetricians and Gynecologists (ACOG)High QualityPremenstrual syndrome and premenstrual dysphoric disorder: diagnosis and management
NICE
This guideline covers diagnosing and managing premenstrual syndrome (PMS) and premenstrual dysphoric disorder (PMDD). It offers recommendations for healthcare professionals on assessment, treatment options, and supporting women.
Clinical GuidelineNICEHigh Quality
Randomized Human Trials(8)
Controlled human studies with random assignment.
Lipoic Acid for Treatment of Progressive Multiple Sclerosis: A Phase 2 Randomized Clinical Trial.
Spain RI, Paz Soldán MM, Freedman MS, Repovic P, Solomon AJ, Rinker JR · Neurology · 2026 · n=118
A pilot trial of the antioxidant lipoic acid (LA) in secondary progressive multiple sclerosis (MS) demonstrated a reduction in the whole-brain atrophy, suggesting neuroprotection. This study determined whether LA preserved walking speed, reduced brain atrophy, and was safe in progressive MS (PMS). This phase 2, 24-month, randomized, double-blind, placebo-controlled clinical trial (2018-2023) recruited a convenience sample from 10 US sites, including 5 Veterans Affairs medical centers and 1 Canadian site. Inclusion criteria were as follows: age ≥18 years, primary or secondary PMS, Expanded Disability Status Scale (EDSS) score 3.0-6.5, and relapse-independent disability worsening in the previous 2 years. Exclusion criteria were as follows: confounders of mobility outcomes, LA use in the previous 2 years, and MRI contraindications. Concurrent disease-modifying therapy (DMT) was permitted. Participants were block-randomized by site (1:1) to receive 1,200 mg daily oral LA or placebo
Randomized TrialPubMedHigh QualitySafari K, Hemmatinafar M, Suzuki K, Koushkie Jahromi M, Imanian B · Nutrients · 2025
Background: Hormonal fluctuations across the menstrual cycle can significantly impair physical performance, neuromuscular function, and cognitive processing in female athletes, particularly during the premenstrual phase. Emerging evidence suggests that dark chocolate (DC), rich in flavonoids, polyphenols, magnesium, and theobromine, may exert anti-inflammatory, analgesic, and neuroprotective effects. This study investigated the acute effects of 85% DC supplementation on cognitive and physical performance, as well as delayed-onset muscle soreness (DOMS), in female CrossFit® athletes across four distinct hormonal phases. Methods: In this randomized, double-blind, placebo-controlled, crossover study, fifteen trained eumenorrheic female CrossFit® athletes completed three intervention conditions: dark chocolate (DC), placebo (PLA), and control (CON). Participants were evaluated during four distinct menstrual phases-menstrual, follicular, luteal, and premenstrual syndrome (PMS)-ove
Randomized TrialPubMedHigh QualityOboza P, Ogarek N, Wójtowicz M, Rhaiem TB, Olszanecka-Glinianowicz M, Kocełak P · Nutrients · 2024
Premenstrual Syndrome (PMS) is a disorder between gynecology and psychiatry which includes cognitive, affective, and somatic symptoms from mild to severe. The most severe form of PMS is premenstrual dysphoric disorder (PMDD) and it is considered a form of depressive disorder. An association between diet composition and the occurrence of PMS and its severity have been suggested. As such, this manuscript discusses the relationships between diet composition, dietary patterns and eating behaviors, and PMS. PubMed, Embase, Cochrane, and Web of Science databases were searched for related studies up to 18 January 2024. A text search with the following keywords singly or in combination was conducted: "Premenstrual syndrome", "Nutrition", "Diet composition", "Dietary patterns", and "Eating behaviors". Studies published so far showed that low intake of simple carbohydrates, fats, salt, and alcohol, and high of fresh, unprocessed foods rich in B vitamins, vitamin D, zinc, calcium, and omega-3 fat
Randomized TrialPubMedHigh Quality
Observational Studies(21)
Cohort, case-control, and cross-sectional human studies.
Piriformis syndrome: a systematic review of case reports.
Monteleone G, Stevanato G, Alimandi M, Cappa E, Sorge R · BMC surgery · 2025 · n=212
To study the medical history, diagnosis, management, and treatment results of piriformis syndrome (PS). Articles published between 1980 and 2024 reporting cases of PS or piriformis muscle sciatica (PMs) case/case series were included. We excluded articles that did not report anagraphic data for singular cases, diagnostic procedure, therapy, and outcome for each case. We searched PubMed database and we retrieved articles from references. We used the Preferred Reporting Items of Systematic Reviews (PRISMA) guidelines to conduct a systematic review of the literature to identify all published cases of PS or piriformis muscle sciatica (PM). Data for all cases were collected in a database and analysed using statistical software (Statistical Package for the Social Sciences for Windows). Of the 235 articles screened, 97 were included. Data from 212 patients (117 females and 95 males, mean age 43.6 ± 14.8) were collected. 38.2% of the patients in this study had a history of blunt / indir
Observational StudyPubMedLow QualityTonello M, Cenzi C, Pizzolato E, Martini M, Pilati P, Sommariva A · Annals of surgical oncology · 2025
National guidelines (GLs) for surgical cytoreduction (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC) in the management of peritoneal malignancies (PMs) vary across countries, scientific societies, and government agencies. This study aimed to systematically review and compare the recommendations for CRS/HIPEC in the treatment of ovarian cancer (EOC), gastric cancer, colorectal cancer (CRC), mesothelioma, and pseudomyxoma peritonei (PMP). Medical databases, search engines, and national websites of 193 countries were queried using artificial intelligence (AI)-powered software for scientific societies and/or government agencies guidelines. The study excluded consensus statements and guidelines without appropriate references. Non-English guidelines were translated, and data, including GRADE strength of recommendations, were extracted. The study analyzed 138 guidelines, 24 for gastric cancer, 36 for colorectal cancer, 29 for primary ovarian cancer (p-)EOC, 28 for recurrent ovar
Observational StudyPubMedLow QualityXu M, Ren H, Liu C, Zhao X, Li X · BMC oral health · 2024
The efficacy of root canal treatment is greatly impacted by a thorough understanding of root canal anatomy. This systematic review and meta-analysis aim to thoroughly investigate the root morphology and canal configuration (RMCC) of permanent premolars (PMs). A comprehensive analysis was conducted following the PRISMA guidelines. Literature exploration was carried out across four electronic databases (PubMed, Embase, Cochrane, and Web of Science). The risk of bias assessment was conducted for the included studies utilizing the Anatomical Quality Assessment (AQUA) tool. Data analysis was performed utilizing SPSS and RevMAN5.3.3. The meta-analysis was applied with a 95% confidence interval to calculate odds ratios (OR). Among the 82 selected studies, 59 studies exhibited potential bias in domain one (objective(s) and subject characteristics), followed by domain three (methodology characterization). The majority of maxillary PM1s had either single root (46.7%) or double roots (51.9%), w
Observational StudyPubMedLow Quality
Clinical Trial Registries(83)
Registered ongoing or completed trials (ClinicalTrials.gov).
n=565 · NCT05509894 · ACTIVE_NOT_RECRUITING · ACTIVE_NOT_RECRUITING
This non-interventional study will be performed by design of post-marketing surveillance (PMS) as an additional pharmacovigilance activity of the Risk Management Plan (RMP) for Ngenla® pre-filled pen injection, which is required by the Ministry of Food and Drug Safety (MFDS) according to the local regulation. This post-marketing surveillance will investigate the safety and effectiveness of Ngenla® pre-filled pen injection as the treatment of children and adolescents from 3 years of age with growth disturbance due to insufficient secretion of growth hormone during 6 years under the setting of routine practice in Korea.
Clinical TrialClinicalTrials.govModerate QualityThe Effect of Acupressure and Yoga on Premenstrual Symptoms and Quality of Life in Coping With PMS
n=153 · NCT04320641 · COMPLETED · COMPLETED
The research was carried out to determine the effect of acupressure and yoga applied to cope with PMS on premenstrual symptoms and quality of life.
Clinical TrialClinicalTrials.govModerate QualityPOST MARKETING SURVEILLANCE STUDY TO OBSERVE SAFETY AND EFFICACY OF INLYTA (REGISTERED)
n=111 · NCT02156895 · COMPLETED · COMPLETED
The objective of this study is to monitor the usage of INLYTA® in real practice, including the adverse events associated with INLYTA®.
Clinical TrialClinicalTrials.govModerate Quality
Working alongside conventional care
Conventional care for PMS often includes lifestyle modifications, over-the-counter pain relievers (NSAIDs), hormonal contraceptives to regulate cycles, and in some cases, antidepressants (SSRIs) for severe mood symptoms, particularly for PMDD. Diuretics may be prescribed for fluid retention.
Related conditions
Latest News
Latest news on PMS
Health Videos
Health videos on PMS
This information is for educational purposes only and not a substitute for professional medical advice. Always consult a healthcare provider before making any decisions about your health or treatment, especially if you are pregnant, nursing, have a medical condition, or are taking medications.
Found something that helped your pms?
Help others see what actually works.
Found something that helped your pms?
Real-world results help others choose what's worth trying.